Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011235
Filing Date
2025-08-12
Accepted
2025-08-12 16:36:27
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20250630x10q.htm   iXBRL 10-Q 1579326
2 EX-31.1 armp-20250630xex31d1.htm EX-31.1 15688
3 EX-31.2 armp-20250630xex31d2.htm EX-31.2 15287
4 EX-32.1 armp-20250630xex32d1.htm EX-32.1 7932
5 EX-32.2 armp-20250630xex32d2.htm EX-32.2 8364
6 GRAPHIC armp-20250630x10q001.jpg GRAPHIC 54059
  Complete submission text file 0001558370-25-011235.txt   7065308

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20250630.xsd EX-101.SCH 46781
8 EX-101.CAL armp-20250630_cal.xml EX-101.CAL 51237
9 EX-101.DEF armp-20250630_def.xml EX-101.DEF 181884
10 EX-101.LAB armp-20250630_lab.xml EX-101.LAB 408049
11 EX-101.PRE armp-20250630_pre.xml EX-101.PRE 326580
80 EXTRACTED XBRL INSTANCE DOCUMENT armp-20250630x10q_htm.xml XML 1202638
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 251207354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)